We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.75B
AUM Growth
+$9.65M
Cap. Flow
+$34.6M
Cap. Flow %
1.26%
Top 10 Hldgs %
19.17%
Holding
309
New
22
Increased
110
Reduced
75
Closed
74

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$25.8M
2
FATE icon
Fate Therapeutics
FATE
+$13.9M
3
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$12.3M
4
STER
Sterling Check Corp. Common Stock
STER
+$10.8M
5
SKYT icon
SkyWater Technology
SKYT
+$9.26M

Top Sells

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$19.8M
2
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$18.5M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$17.9M
4
EVER icon
EverQuote
EVER
+$13M
5
ECHO
Echo Global Logistics, Inc.
ECHO
+$12.4M

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Healthcare 20.11%
3 Consumer Discretionary 16.66%
4 Industrials 15.03%
5 Financials 13.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMSI icon
26
Merit Medical Systems
MMSI
$4.41B
$32.3M 1.17%
449,787
+80,586
+22% +$5.47M
SMTC icon
27
Semtech
SMTC
$11.6B
$32.1M 1.16%
411,291
+95,153
+30% +$6.52M
TREX icon
28
Trex
TREX
$4.69B
$30.7M 1.12%
301,422
-79,325
-21% -$8.29M
ONTO icon
29
Onto Innovation
ONTO
$13.9B
$29.2M 1.06%
404,492
-42,624
-10% -$3.07M
BHVN
30
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$28.8M 1.04%
+207,006
New +$25.8M
DIOD icon
31
Diodes
DIOD
$4B
$28.3M 1.03%
312,316
+35,589
+13% +$3.11M
ATRC icon
32
AtriCure
ATRC
$1.77B
$28.1M 1.02%
403,989
-93,040
-19% -$7.16M
LOB icon
33
Live Oak Bancshares
LOB
$1.97B
$28.1M 1.02%
441,383
+13,890
+3% +$823K
RETA
34
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$27.8M 1.01%
276,155
+29,712
+12% +$3.48M
YETI icon
35
Yeti Holdings
YETI
$3.87B
$27.6M 1%
321,830
+624
+0.2% +$60.4K
REPL icon
36
Replimune Group
REPL
$859M
$27.3M 0.99%
921,775
+189,533
+26% +$6.16M
BRBR icon
37
BellRing Brands
BRBR
$1.41B
$26.8M 0.97%
873,086
-328,807
-27% -$10.5M
SAIL
38
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$26.8M 0.97%
625,611
+19,140
+3% +$908K
VIAV icon
39
Viavi Solutions
VIAV
$9.41B
$26M 0.94%
1,652,849
+19,810
+1% +$325K
KRTX
40
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$25.9M 0.94%
212,022
+7,608
+4% +$878K
PLNT icon
41
Planet Fitness
PLNT
$4.14B
$25.6M 0.93%
326,498
+11,003
+3% +$836K
KTOS icon
42
Kratos Defense & Security Solutions
KTOS
$8.63B
$25.6M 0.93%
1,145,411
-82,459
-7% -$2.04M
COHU icon
43
Cohu
COHU
$2.41B
$25.5M 0.93%
799,029
+102,706
+15% +$3.49M
NVEE
44
DELISTED
NV5 Global
NVEE
$25M 0.91%
1,014,308
+37,376
+4% +$921K
RAMP icon
45
LiveRamp
RAMP
$2.3B
$24.4M 0.88%
515,759
+60,136
+13% +$2.71M
BPMC
46
DELISTED
Blueprint Medicines
BPMC
$24M 0.87%
233,508
+7,173
+3% +$668K
ARVN icon
47
Arvinas
ARVN
$517M
$23.4M 0.85%
284,541
+15,779
+6% +$1.39M
HLI icon
48
Houlihan Lokey
HLI
$9.67B
$23.2M 0.84%
251,723
+8,843
+4% +$775K
ITGR icon
49
Integer Holdings
ITGR
$3.24B
$22.7M 0.82%
254,188
+41,532
+20% +$3.89M
OCFC icon
50
OceanFirst Financial
OCFC
$1.73B
$22.4M 0.81%
1,048,118
+29,220
+3% +$599K
1
2
3 4 5

Similar funds

AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Emerald Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Emerald Advisers held 309 positions worth $2.75B, up 0.35% from $2.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers's Q3 2021 filing shows 22 new, 110 increased, 75 reduced and 74 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M. The largest sale was The AZEK Co, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M.
  • Emerald Advisers added most to SkyWater Technology in Q3 2021, an estimated $9.26M increase.
  • Emerald Advisers's biggest Q3 2021 reduction was EverQuote, cutting an estimated $13M.
  • Emerald Advisers fully exited The AZEK Co in Q3 2021, selling an estimated $19.8M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.75B portfolio in Q3 2021.
  • Emerald Advisers opened 22 new positions and closed 74 in Q3 2021.
  • Emerald Advisers's portfolio value rose 0.35% quarter-over-quarter to $2.75B.

Based on Emerald Advisers's 13F filing for Q3 2021, filed 28 Oct 2021.